Sektor Lineage Cell Therapeutics, Inc.

Aktien

A2PP89

US53566P1093

LCTX

Biotechnologie

Markt geschlossen - 22:00:00 28.09.2026 Perf. 5 T Veränd. 1. Jan.
0.9710 USD -5.73% Intraday Chart für Lineage Cell Therapeutics, Inc. -5.73% -41.86%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
-5.73%-5.73%-16.29%-24.14%-41.86%-43.22%-18.40%-63.63%-74.65% 260 Mio.
+2.64%+7.07%-0.71%+9.28%+8.63%+11.87%+38.40%-19.04%+218.89% 47.97 Mrd.
+0.22%+1.71%+3.27%+41.77%+20.21%+50.91%+34.00%+9.20%+239.99% 44.5 Mrd.
-1.58%+5.65%-8.78%+10.80%+153.28%+359.34%+598.06%+577.43% - 43.93 Mrd.
+1.70%+4.61%-1.47%+31.12%+20.80%+12.56%+90.97%-2.70%+1’144.49% 41.03 Mrd.
+0.51%-0.61%-6.80%+7.47%+3.43%+5.18%+46.87%-18.93%+132.36% 29.85 Mrd.
-0.48%+0.59%+0.71%+16.86%+9.67%+23.98%+148.36%+222.43%+2’000.75% 17.27 Mrd.
+0.08%+9.30%+20.36%+51.55%+44.08%+8.41% - - - 15.34 Mrd.
+1.76%+2.98%+7.84%+14.15%+26.15%+29.13%+45.78%-30.95%+95.04% 15.3 Mrd.
+1.97%-2.82%-7.74%-11.77% - - - - - 14.82 Mrd.
+0.60%+5.94%-0.61%+36.54%+47.68%+98.30%+51.12%-31.88%+250.95% 13.98 Mrd.
+1.88%+6.98%+3.45%+3.36%-3.65%+7.19%-29.23%-35.26%+127.16% 13.3 Mrd.
-2.19%+6.76%+18.38%+256.23%+238.16%+167.86%+101.44%+32.49%+1’734.06% 12.48 Mrd.
-0.14%+0.19%+0.06%+2.13%+23.30%+39.85%+7.31%-43.29%+165.19% 11.39 Mrd.
-0.85%-0.39%-4.37%+63.87%+51.71%+28.48%+39.81%-54.86% - 10.96 Mrd.
+0.04%-4.88%-6.85%+3.59%+43.94%+99.11%+659.32%+76.13% - 9.31 Mrd.
+0.41%-0.39%-4.72%+16.87%+63.09%+111.27%+710.70%+643.42%+578.61% 9.18 Mrd.
+1.88%+3.88%+2.90%+14.21%-4.92%-2.60%+2.17%-23.40%+43.18% 9.14 Mrd.
+2.38%-7.86%-16.11%-0.77%-30.36%+19.27%+453.83%+184.72%+981.94% 8.14 Mrd.
+1.73%-4.45%-22.35%-12.86%-3.08%+444.72%+1’178.08%-10.80% - 7.84 Mrd.
Durchschnitt +0.34%+0.88%-1.99%+26.51%+35.28%+77.45%+231.03%+78.39%+545.57% 18.8 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +0.66%+2.26%-1.01%+26.82%+42.45%+83.52%+190.09%+97.61%+549.71%
  1. Börse
  2. Aktien
  3. A2PP89 Aktie
  4. Sektor Lineage Cell Therapeutics, Inc.
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT